ABG Analytics logo
Get updates

Celgene Corp (NASDAQ: CELG)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 09/20/2019
Closing price: 99.37
Support price level: $94.94
Resistance price level: N/A
Relative strength index (14-day RSI) 82.5
Beta 1.26
  • CELG is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.

  • Volatility is forecast to rise over the next month.

  • With RSI > 70, CELG is overbought. Odds slightly favor a short-term price reversal.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$59.21 $99.37 100.0%
200 day 50 day 20 day 10 day
$90.02 $94.79 $97.58 $98.41
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
31.0% 21.9% 20.9% 27.1%
There is an estimated 5% probability that the stock price of Celgene Corp will fall by more than:
  • 5.7% in the next week.

  • 15.4% in the next month.

  • 59.9% in the next year.